Volume 107, Issue 3 p. 382-395

Randomised clinical trials of fish oil supplementation in high risk pregnancies

Sjúrour F. Olsen

Corresponding Author

Sjúrour F. Olsen

Senior Scientist

Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, Copenhagen, Denmark

Correspondence: Dr S. F. Olsen (email: [email protected]), Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark

Correspondence: Professor N. J. Secher (email: [email protected]), Perinatal Epidemiological Research Unit, Department of Obstetrics and Gynaecology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.

Search for more papers by this author
Niels J. Secher

Corresponding Author

Niels J. Secher

Professor

Perinatal Epidemiological Research Unit, Department of Obstetrics and Gynaecology, Aarhus University Hospital, Denmark

Correspondence: Dr S. F. Olsen (email: [email protected]), Maternal Nutrition Group, Danish Epidemiology Science Centre, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark

Correspondence: Professor N. J. Secher (email: [email protected]), Perinatal Epidemiological Research Unit, Department of Obstetrics and Gynaecology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark.

Search for more papers by this author
Ann Tabor

Ann Tabor

Chief Physician

Department of Obstetrics and Gynaecology, Hvidovre University Hospital, Copenhagen, Denmark

Search for more papers by this author
Tom Weber

Tom Weber

Chief Physician

Department of Obstetrics and Gynaecology, Hvidovre University Hospital, Copenhagen, Denmark

Search for more papers by this author
James J. Walker

James J. Walker

Professor

St James University Hospital, Leeds, West Yorkshire

Search for more papers by this author
Christian Gluud

Christian Gluud

Chief Physician

Copenhagen Trial Unit, Centre for Clinical Intervention Research, Institute of Preventive Medicine, Copenhagen University Hospital, Denmark

Search for more papers by this author
First published: 12 August 2005
Citations: 256

For a list of all members of the Fish Oil Trials In Pregnancy (FOTIP) Team see page 393

Abstract

Objective To test the postulated preventive effects of dietary n-3 fatty acids on pre-term delivery, intrauterine growth retardation, and pregnancy induced hypertension.

Design In six multicentre trials, women with high risk pregnancies were randomly assigned to receive fish oil (Pikasol) or olive oil in identically-looking capsules from around 20 weeks (prophylactic trials) or 33 weeks (therapeutic trials) until delivery.

Setting Nineteen hospitals in Europe.

Samples Four prophylactic trials enrolled 232, 280, and 386 women who had experienced previous pre-term delivery, intrauterine growth retardation, or pregnancy induced hypertension respectively, and 579 with twin pregnancies. Two therapeutic trials enrolled 79 women with threatening pre-eclampsia and 63 with suspected intrauterine growth retardation.

Interventions The fish oil provided 2.7 g and 6.1 g n-3 fatty acids/day in the prophylactic and therapeutic trials, respectively.

Main outcome measures Preterm delivery, intrauterine growth retardation, pregnancy induced hypertension.

Results Fish oil reduced recurrence risk of pre-term delivery from 33% to 21% (odds ratio 0.54 (95% CI 0.30 to 0.98)) but did not affect recurrence risks for the other outcomes (OR 1.26; 0.74 to 2.12 and 0.98; 0.63 to 1.53, respectively). In twin pregnancies, the risks for all three outcomes were similar in the two intervention arms (95% CI for the three odds ratios were 0.73 to 1.40, 0.90 to 1.52, and 0.83 to 2.32, respectively). The therapeutic trials detected no significant effects on pre-defined outcomes. In the combined trials, fish oil delayed spontaneous delivery (proportional hazards ratio 1.22; 1.07 to 1.39, P= 0.002).

Conclusions Fish oil supplementation reduced the recurrence risk of pre-term delivery, but had no effect on pre-term delivery in twin pregnancies. Fish oil had no effect on intrauterine growth retardation and pregnancy induced hypertension, affecting neither recurrence risk nor risk in twin pregnancies.